Temodar Related Clinical Trials
A Phase II Study of Temozolomide (TEMODAR) in the Treatment of Adult Patients With Supratentorial Low Grade Glioma [Recruiting]
Sarasar and Temodar for Glioblastoma Multiforme Patients [Active, not recruiting]
Phase II Study of 7 Days On/7 Days Off Temozolomide in Patients With High-Grade Glioma [Recruiting]
Ph I 5-Day Temo + O6-BG in Treatment of Pts w Recurrent / Progressive GBM [Active, not recruiting]
Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma [Active, not recruiting]
Ph. II Temo + O6-BG in Treatment of Pts w Temo-Resistant Malignant Glioma [Active, not recruiting]
Taxotere/Temodar/Cisplatin Study in Melanoma Patients [Active, not recruiting]
Avastin/Radiation (XRT)/Temozolomide Followed by Avastin/Temozolomide/Topotecan for Glioblastoma [Recruiting]
Phase II Study of Gamma Knife Radiosurgery and Temozolomide for Brain Metastases [Active, not recruiting]
Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM [Active, not recruiting]
Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM) [Recruiting]
Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors [Recruiting]
Thalidomide in Combination With Temodar in Patients With Neuroendocrine Tumors [Completed]
Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme [Active, not recruiting]
Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Patients With Medulloblastomas With an Activation of the Sonic Hedgehog Pathway [Recruiting]
Study of Temozolomide in Previously Untreated Acute Myeloid Leukemia Patients With Low MGMT Expression (Study P05052) [Recruiting]
Neo-adjuvant Treatment With Temozolomide and Bevacizumab Previous to Temozolomide Plus Radiation Plus Bevacizumab Therapy in Unresectable Glioblastoma [Recruiting]
Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED) [Completed]
Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma [Not yet recruiting]
A Phase I/II Study of TPI 287 - Temozolomide Combination in Melanoma [Recruiting]
Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma [Recruiting]
Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2) [Recruiting]
Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme Multiforme [Recruiting]
A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma [Recruiting]
Trial Of Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (TEMODAR) For Treatment Of Newly Diagnosed Glioblastoma Multiforme And Anaplastic Astrocytoma [Recruiting]
Prolonged Adjuvant Temozolomide vs "Stop & Go" in Glioblastoma Patients [Recruiting]
Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer [Recruiting]
A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas [Recruiting]
High Dose Interleukin-2 Followed by Intermittent Low Dose Temozolomide in Patients With Melanoma [Recruiting]
Phase I Factorial Trial of Temozolomide, Memantine, Mefloquine, and Metformin for Post-Radiation Therapy (RT) Glioblastoma Multiforme (GBM) [Recruiting]
ABT-888 and Temozolomide for Liver Cancer [Recruiting]
Safety Study of XL184 in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma [Recruiting]
A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma [Recruiting]
Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery [Recruiting]
Ph. I Temo + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas [Active, not recruiting]
Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma [Recruiting]
Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma [Recruiting]
Bevacizumab, Irinotecan and Temozolomide for Relapsed or Refractory Neuroblastoma [Recruiting]
Phase II Trial of Chemotherapy With Temodar With Topotecan for CNS Metastasis of Solid Tumors [Recruiting]
Study of Temozolomide to Treat Newly Diagnosed Brain Metastases [Recruiting]
Safety Study of High Dose Temozolomide to Treat Relapsed/Refractory Central Nervous System (CNS) Malignancy [Recruiting]
Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma [Recruiting]
Doxycycline, Temozolomide and Ipilimumab in Melanoma [Recruiting]
A Study of ABT-888 in Combination With Temozolomide for Colorectal Cancer [Recruiting]
Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer [Recruiting]
The Effects of Continuous 28-Day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-Day (5/28) Treatment (P04601AM1) [Active, not recruiting]
Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients [Recruiting]
Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors [Active, not recruiting]
Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temo [Active, not recruiting]
Prolonged Daily Temozolomide for Low-Grade Glioma [Active, not recruiting]
Radiation Boost for Newly Diagnosed Glioblastoma Multiforme [Terminated]
A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma [Active, not recruiting]
Carboplatin and Temozolomide (Temodar) for Recurrent and Symptomatic Residual Brain Metastases
Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267AM2)(COMPLETED) [Completed]
Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Active, not recruiting]
Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma [Suspended]
Tailored Temozolomide Therapy for Patients With AML and Poor Prognostic Features
Avastin in Combo w XRT & Temozolomide , Followed by Avastin, Temozolomide & Irinotecan for GBM & Gliosarcomas [Recruiting]
Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma [Recruiting]
Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma
Aerosol L9-NC and Temozolomide in Ewing's Sarcoma [Recruiting]
Temozolomide in Concomitant Radiochemotherapy Followed by Sequential Temozolomide Chemotherapy - Observational Program (Study P04816) [Recruiting]
Temozolomide in Treating Patients With Recurrent Malignant Glioma [Active, not recruiting]
Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma [Recruiting]
Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas [Active, not recruiting]
Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572) [Recruiting]
DepoCyt Plus Temozolomide in Patients With Neoplastic Meningitis [Recruiting]
Ph I Trial of Oral Topotecan + Temozolomide in Treatment of Pts w Malignant Gliomas [Recruiting]
Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer [Completed]
Radiation Therapy Combined With Either Gefitinib or Temozolomide in Treating Patients With Non-Small Cell Lung Cancer and Brain Metastases [Recruiting]
Gliadel Wafers and Temodar in the Treatment of Glioblastoma Multiforme [Recruiting]
Dose-Dense Temozolomide + Lapatinib for Recurrent Ependymoma [Not yet recruiting]
A Phase II Study of Gliadel, Concomitant Temozolomide and Radiation, Followed By Dose Dense Therapy With Temozolomide For Newly Diagnosed Malignant High Grade Glioma [Recruiting]
Temozolomide in Treating Patients With Primary Brain Tumors or Metastatic Brain Tumors [Recruiting]
Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy [Recruiting]
Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas [Recruiting]
A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma [Recruiting]
Safety and Tolerability of Low-Dose Temozolomide During Whole Brain Radiation in Patients With Cerebral Metastases From Non-Small-Cell Lung Cancer (Study P04071) [Recruiting]
Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Active, not recruiting]
Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM [Recruiting]
Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma [Active, not recruiting]
PH I Addition of Farnesyl Transferase Inhibitor to Temo for Pts w Gr 3 & 4 Malignant Gliomas [Recruiting]
Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients [Recruiting]
IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma [No longer recruiting]
Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma [Recruiting]
Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma [No longer recruiting]
Abraxane and Temodar Plus Genasense in Advanced Melanoma [Recruiting]
Dose-Intense Temozolomide in Recurrent Glioblastoma [Recruiting]
Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma [Active, not recruiting]
Bevacizumab, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma Previously Treated With Radiation Therapy and Temozolomide [Recruiting]
RAD001 and Temozolomide in Patients With Advanced Pancreatic Neuroendocrine Tumors [Recruiting]
Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme [Recruiting]
Biochemotherapy With Temozolomide for Metastatic Melanoma [Recruiting]
Valproic Acid, Temozolomide, and Radiation Therapy in Treating Patients With Glioblastoma Multiforme [Recruiting]
Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma [No longer recruiting]
6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients [Recruiting]
Temodar and Sutent as Therapy for Melanoma [Recruiting]
Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma [Recruiting]
Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM1) [Recruiting]
Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-Tenascin Radiolabeled Antibody Therapy [Recruiting]
|
